Blueberry Therapeutics Home 2018-02-16T15:27:13+00:00

Blueberry Therapeutics have unique nanopolymer drug delivery technology which opens up huge opportunities to rapidly develop new medicines and helps us find ways to treat dermatological disorders.


Blueberry is committed to the development of innovative new therapies for the treatment of common dermatological disorders.


We use cutting-edge nano polymer drug delivery technology to exploit both small molecule and biologic approaches to developing treatments.

Blueberry Nanomedicine


A Blueberry case study

In this video, CEO John Ridden and CSO David Cook talk about the early days of Blueberry Therapeutics, the short term and long term plans for the company, and the benefits of being based at Alderley Park, Cheshire.

Drugs in our pipeline
Patents and exclusives licences
Billion dollars in commercial potential

T: 01625 238776

Blueberry Therapeutics Ltd
Blueberry Therapeutics, Mereside, Alderley Park, Alderley Edge, Cheshire, SK10 4TG.